Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034797939> ?p ?o ?g. }
- W2034797939 endingPage "742" @default.
- W2034797939 startingPage "733" @default.
- W2034797939 abstract "To investigate the safety, biological effects, and efficacy of the anti-tumor necrosis factor (TNF) antibody fragment, MAK 195F, in a phase II trial in patient with severe sepsis.Prospective, randomized, open label, placebo-controlled, dose-ranging, multicenter, multinational clinical trial.Sixteen academic medical centers' intensive care units in six European countries.One hundred twenty-two patients with severe sepsis or septic shock who received standard supportive care and antimicrobial therapy.Patients received one of three different doses of the anti-TNF antibody (0.1 mg/kg, 0.3 mg/kg, or 1.0 mg/kg) or placebo; the antibody or placebo was given in nine doses at 8-hr intervals over 3 days.There were no significant differences in mortality rates among the groups receiving various doses of the anti-TNF antibody or placebo, but patients with baseline serum interleukin (IL)-6 concentrations of > 1000 pg/mL appeared to benefit from MAK 195F in a dose-dependent fashion. Increased circulating IL-6 concentrations, but not TNF concentrations, were found to be important prognostic indicators for mortality for the patients in the placebo and the two lower dosage groups but not in the high dosage group (1 mg/kg). IL-6 concentrations decreased during the first 24 hrs of treatment in all three anti-TNF groups but not in the placebo group. MAK 195F was well tolerated by all patients. Human antimurine antibodies developed in 40% of the patients receiving the antibody.There was no increase in survival from sepsis for the patients receiving anti-TNF treatment in the overall study population. Retrospective stratification of patients by IL-6 concentrations suggests beneficial effects of the drug for patients with baseline circulating IL-6 concentrations of > 1000 pg/mL. This hypothesis requires validation in a larger, blinded, prospective study." @default.
- W2034797939 created "2016-06-24" @default.
- W2034797939 creator A5001177637 @default.
- W2034797939 creator A5016594337 @default.
- W2034797939 creator A5022238495 @default.
- W2034797939 creator A5024271702 @default.
- W2034797939 creator A5028106526 @default.
- W2034797939 creator A5034495370 @default.
- W2034797939 creator A5042192496 @default.
- W2034797939 creator A5045251268 @default.
- W2034797939 creator A5060657934 @default.
- W2034797939 creator A5066025130 @default.
- W2034797939 creator A5069433703 @default.
- W2034797939 creator A5072862143 @default.
- W2034797939 creator A5084935661 @default.
- W2034797939 creator A5085687822 @default.
- W2034797939 date "1996-05-01" @default.
- W2034797939 modified "2023-10-15" @default.
- W2034797939 title "Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock" @default.
- W2034797939 cites W1964923202 @default.
- W2034797939 cites W1973313699 @default.
- W2034797939 cites W1984641211 @default.
- W2034797939 cites W1988243363 @default.
- W2034797939 cites W1994917617 @default.
- W2034797939 cites W1996970972 @default.
- W2034797939 cites W2004536137 @default.
- W2034797939 cites W2028207517 @default.
- W2034797939 cites W2029343390 @default.
- W2034797939 cites W2030235062 @default.
- W2034797939 cites W2030879735 @default.
- W2034797939 cites W2031051797 @default.
- W2034797939 cites W2038434279 @default.
- W2034797939 cites W2039602526 @default.
- W2034797939 cites W2063182519 @default.
- W2034797939 cites W2065699321 @default.
- W2034797939 cites W2078110114 @default.
- W2034797939 cites W2083157865 @default.
- W2034797939 cites W2093799856 @default.
- W2034797939 cites W2097599259 @default.
- W2034797939 cites W2112875552 @default.
- W2034797939 cites W2114563054 @default.
- W2034797939 cites W2114784836 @default.
- W2034797939 cites W2116064835 @default.
- W2034797939 cites W2119566781 @default.
- W2034797939 cites W2142585662 @default.
- W2034797939 cites W2144509548 @default.
- W2034797939 cites W2146732421 @default.
- W2034797939 cites W2151101205 @default.
- W2034797939 cites W2157825442 @default.
- W2034797939 cites W2162428378 @default.
- W2034797939 cites W2321427723 @default.
- W2034797939 cites W2332739634 @default.
- W2034797939 cites W4236884179 @default.
- W2034797939 cites W4293242440 @default.
- W2034797939 cites W4298273896 @default.
- W2034797939 cites W4322697531 @default.
- W2034797939 cites W76818083 @default.
- W2034797939 doi "https://doi.org/10.1097/00003246-199605000-00003" @default.
- W2034797939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8706447" @default.
- W2034797939 hasPublicationYear "1996" @default.
- W2034797939 type Work @default.
- W2034797939 sameAs 2034797939 @default.
- W2034797939 citedByCount "348" @default.
- W2034797939 countsByYear W20347979392012 @default.
- W2034797939 countsByYear W20347979392013 @default.
- W2034797939 countsByYear W20347979392014 @default.
- W2034797939 countsByYear W20347979392015 @default.
- W2034797939 countsByYear W20347979392016 @default.
- W2034797939 countsByYear W20347979392017 @default.
- W2034797939 countsByYear W20347979392018 @default.
- W2034797939 countsByYear W20347979392019 @default.
- W2034797939 countsByYear W20347979392020 @default.
- W2034797939 countsByYear W20347979392021 @default.
- W2034797939 countsByYear W20347979392022 @default.
- W2034797939 countsByYear W20347979392023 @default.
- W2034797939 crossrefType "journal-article" @default.
- W2034797939 hasAuthorship W2034797939A5001177637 @default.
- W2034797939 hasAuthorship W2034797939A5016594337 @default.
- W2034797939 hasAuthorship W2034797939A5022238495 @default.
- W2034797939 hasAuthorship W2034797939A5024271702 @default.
- W2034797939 hasAuthorship W2034797939A5028106526 @default.
- W2034797939 hasAuthorship W2034797939A5034495370 @default.
- W2034797939 hasAuthorship W2034797939A5042192496 @default.
- W2034797939 hasAuthorship W2034797939A5045251268 @default.
- W2034797939 hasAuthorship W2034797939A5060657934 @default.
- W2034797939 hasAuthorship W2034797939A5066025130 @default.
- W2034797939 hasAuthorship W2034797939A5069433703 @default.
- W2034797939 hasAuthorship W2034797939A5072862143 @default.
- W2034797939 hasAuthorship W2034797939A5084935661 @default.
- W2034797939 hasAuthorship W2034797939A5085687822 @default.
- W2034797939 hasConcept C126322002 @default.
- W2034797939 hasConcept C141071460 @default.
- W2034797939 hasConcept C142724271 @default.
- W2034797939 hasConcept C159654299 @default.
- W2034797939 hasConcept C17991360 @default.
- W2034797939 hasConcept C203014093 @default.
- W2034797939 hasConcept C204787440 @default.
- W2034797939 hasConcept C27081682 @default.